| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.006 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |